Predicting response to lithium in mood disorders: role of genetic polymorphisms.
about
Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidationNeural network analysis in pharmacogenetics of mood disordersInterindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.Differences between opioids: pharmacological, experimental, clinical and economical perspectivesUGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patientsWorldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.Pharmacogenomics in depression and antidepressantsPharmacogenetics of opioids.Analgesia and central side-effects: two separate dimensions of morphine response.Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrate.The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivoPhRMA white paper on ADME pharmacogenomics.Variable response to opioid treatment: any genetic predictors within sight?Pharmacogenetics of analgesics: toward the individualization of prescription.Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.Pharmacogenetics of pain and analgesia.Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid.Pharmacogenomics of opioids and perioperative pain management.A Case-Based Approach to Integrating Opioid Pharmacokinetic and Pharmacodynamic Concepts in Cancer Pain Management.The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.The pharmacogenetics of codeine pain relief in the postpartum period.Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.UGT1A6- and UGT2B7-related valproic acid pharmacogenomics according to age groups and total drug concentration levels.In vitro glucuronidation of aprepitant: a moderate inhibitor of UGT2B7.Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of AcetaminophenRash and multiorgan dysfunction following lamotrigine: could genetic be involved?Influence of uridine diphosphate-glucuronyltransferase 2B7 (UGT2B7) variants on postoperative buprenorphine analgesia.Clinical response to morphine in cancer patients and genetic variation in candidate genes.Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.Effect of UGT2B7 -900G>A (-842G>A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohort.Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.Why is there no morphine concentration-response curve for acute pain?Association of genetic variants in six candidate genes with valproic acid therapy optimization.Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
P2860
Q24648578-ACA238D6-4D8A-479C-91F6-194245549E89Q24792166-FC1D2CFB-7645-4803-98D2-BADBCBA28E96Q33451969-5876D032-EC81-4CDB-9403-D011D6E58529Q33664128-35F8C7FA-F66E-4970-98F7-96263E99EF96Q34272502-DB356BD7-25B4-451F-978D-7F2B45B9757BQ34984788-640E8C15-2DC2-46D3-B701-7794DAFF1289Q35008045-FD1D6615-F254-4176-8342-E733CA6FCDC0Q35558084-920137AC-A8C6-4202-9822-84CC55854357Q35578549-703A5A7A-E475-4B2D-AF88-26E7D430C112Q36079108-978E92D0-75A0-4854-AC68-C4D537BF918CQ36255125-D36961F1-0E96-4537-ABB9-08016A59D304Q36752672-7243A6C8-B2F8-4662-B966-6A28F8E797ACQ36792999-962E3754-3FC7-45D9-9651-28A130013012Q36834217-D2D30224-B89C-4644-BA28-E526387BCADBQ37107040-F6BEE942-C7E9-4B87-8077-A7772A4E8767Q37182212-395358BB-AFA8-43A6-B132-3A2516929C3EQ37187101-7F243C11-AA8F-448D-91F2-61469760A3B1Q37205954-CB21B455-3363-4263-9CB9-C8F8A64C4472Q37264538-9BEC0664-915C-4C28-831D-31C3A91A4900Q38025139-7F046E9F-E04C-4BF8-95CE-C85F6029F624Q38030052-835D1027-5AAE-4E0B-AF44-1FE48BD9078DQ38061498-B59673C6-A3F7-45D4-8793-81957CD30D62Q38655206-D6B56D21-F30E-4976-8C5A-60811EE43653Q38664725-363A33BC-9926-4839-ABDD-C7285C8EFE25Q39192887-878B98FA-CB35-4496-BF38-0C56E3DBB023Q39198915-69E72881-5FB0-4D94-B45C-852775D625D7Q39731863-A8311A44-446F-48D1-BE13-B0D9C4D2F918Q40600601-324589F2-3FF4-4E99-8C09-22916969FF2BQ40789462-D4FEC2C9-64A7-4951-BE7D-A771C1A428FFQ41078858-77BA5EEF-10B0-4C60-B6DC-635DB282DEC6Q41587506-DBEC1DF7-53DB-44A2-9814-ADF7A0573E4BQ45879292-E84B12D9-56BD-400C-86BD-E8F4765DD300Q46653217-5749F611-9733-4458-BBA7-5B539D3863C1Q47306035-9C1F5975-9722-4B4A-9DDA-27E8E6DF19F8Q47796637-661A126F-B45C-478F-9D96-BE1EDD54BD01Q48490118-9172D5D4-6BA1-423C-98DE-C90BB138C5A7Q51004632-4CFAA711-E71B-4E14-84A1-7F7011445E83Q51119182-159112F8-81A4-4C4F-AC46-BF027E997240Q53210224-DCBC8A32-19C8-4106-91D1-B29829AAE9A6Q55055431-B6A38E4F-5A7E-4BE4-95A0-88D36EEF8A6D
P2860
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
@ast
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
@en
type
label
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
@ast
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
@en
prefLabel
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
@ast
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
@en
P2860
P356
P1476
Predicting response to lithium in mood disorders: role of genetic polymorphisms.
@en
P2093
Alessandro Serretti
Paola Artioli
P2860
P2888
P356
10.1038/SJ.TPJ.6500139
P577
2003-01-01T00:00:00Z
P5875
P6179
1011733756